^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    OlyCAR-019

    i
    Other names: OlyCAR-019, Anti-CD19 Autologous CAR-T Cell Infusion
    Associations

    News

    Trials
    Company:
    920th Hospital of Joint Logistics Support Force of the Chinese People's Liberation Army
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over1year
    A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies (clinicaltrials.gov)
    P1/2, N=60, Recruiting, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
    New P1/2 trial
    |
    OlyCAR-019